Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Novel drug delivery approaches in dry eye syndrome therapy
Publication

Publications

Novel drug delivery approaches in dry eye syndrome therapy

Title
Novel drug delivery approaches in dry eye syndrome therapy
Type
Chapter or Part of a Book
Year
2010
Authors
Doktorovova, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Araujo, JR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Egea, MA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Garcia, ML
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Souto, EB
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Indexing
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-008-YVA
Abstract (EN): Dry eye syndrome or the keratoconjunctivitis sicca is a common disease of tear film and ocular surface developed in numerous aetiologies. Tear film instability and ocular surface disturbances that subsequently influence the tear film are among the primarily causes of this disease, but many other factors are involved in tear film disorders. Clinical manifestations commonly include eye discomfort, feeling of a foreign body in the eye, itching or even visual disturbance; inflammation and damage of ocular surface may follow. The therapeutic approaches are based on the dry eye symptoms relief, increasing the patient's comfort and preventing further damage to ocular surface. This can be achieved by renewing the normal function of tear film and ocular surfaces. Although eye surface is easily reached by classical ocular dosage forms, novel drug delivery systems for ocular administration offer advantages in terms of increased residence time on eye surface and/or controlled release of the drug, with enhanced therapeutic effectiveness. Patient's acceptance can also be improved by developing formulations that do not require frequent application, or cause blurred vision, and having a more pleasant appearance. Biodegradable, biocompatible, non-toxic, and mucoadhesive materials are being used for the design of colloidal carriers. Novel polymers for hydrogels suitable for ocular administration are reviewed in this chapter, giving overview on their potential benefits and limitations in dry eye syndrome management and reported successful formulations.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same book

Pharmacological treatment of ocular inflammatory diseases with novel lipid based drug delivery systems (2010)
Chapter or Part of a Book
Gratieri, T; Gonzalez Mira, E; Lopez, RFV; Egea, MA; Garcia, ML; Souto, EB
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-18 at 01:08:37 | Privacy Policy | Personal Data Protection Policy | Whistleblowing